Author:
Ivanova Reipold Elena,Easterbrook Philippa,Trianni Alessandra,Panneer Nivedha,Krakower Douglas,Ongarello Stefano,Roberts Teri,Miller Veronica,Denkinger Claudia
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017. http://apps.who.int/iris/bitstream/10665/254621/1/9789241549981-eng.pdf?ua=1 . Accessed June 2017.
2. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333–42.
3. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1 . Accessed June 2017.
4. Pol S, Corouge M, Vallet-Pichard A. Daclatasvir-sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life. Hepat Med. 2016;8:21–6.
5. Andrieux-Meyer I, Cohn J. Affonso de Araujo E, Hamid S. Disparity in market prices for hepatitis C virus direct-acting drugs. Lancet. 2015;3:e676–7.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献